Stony Brook Southampton Hospital Regional Dialysis Center in Hampton Bays, New York - Dialysis Center

Stony Brook Southampton Hospital Regional Dialysis Center is a medicare approved dialysis facility center in Hampton Bays, New York and it has 17 dialysis stations. It is located in Suffolk county at 184 West Montauk Hgwy, Hampton Bays, NY, 11946. You can reach out to the office of Stony Brook Southampton Hospital Regional Dialysis Center at (631) 723-4200. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. Stony Brook Southampton Hospital Regional Dialysis Center has the following ownership type - Non-Profit. It was first certified by medicare in March, 2000. The medicare id for this facility is 333533 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameStony Brook Southampton Hospital Regional Dialysis Center
Location184 West Montauk Hgwy, Hampton Bays, New York
No. of Dialysis Stations 17
Medicare ID333533
Managed ByIndependent
Ownership TypeNon-Profit
Late Shifts Yes

Contact Information


184 West Montauk Hgwy, Hampton Bays, New York, 11946
(631) 723-4200

News Archive

New line of household disinfectant wipes and sprays launched

Seventh Generation, the nation's leading brand of non-toxic, environmentally safe household solutions, incorporates the latest breakthrough in green chemistry with the introduction of a new line of household disinfectant wipes and sprays.

Tackling food allergies: is immunotherapy the answer?

Food allergies affect approximately 8% of school children in the United States and the United Kingdom. The highest prevalence of food allergies is in Australia affecting approximately 10% of young children. It is lower in the developing world.

Apollo signs license option deal with Case Western to develop point-of-care blood analyzer

A blood test yields a wealth of information crucial to a person's health. What's needed is a device that is small and inexpensive, yet capable of quickly providing a thorough analysis using a very small sample.

Gentium completes Defibrotide clinical studies, plans to file for regulatory approval

Gentium S.p.A. today announced that ongoing preclinical and clinical studies on Defibrotide have been completed and confirmed its plan to file for regulatory approval of Defibrotide with the US Food and Drug Administration and the European Medicines Agency by the end of the second quarter of 2011.

Read more Medical News

› Verified 5 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Stony Brook Southampton Hospital Regional Dialysis Center from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data36
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL17

News Archive

New line of household disinfectant wipes and sprays launched

Seventh Generation, the nation's leading brand of non-toxic, environmentally safe household solutions, incorporates the latest breakthrough in green chemistry with the introduction of a new line of household disinfectant wipes and sprays.

Tackling food allergies: is immunotherapy the answer?

Food allergies affect approximately 8% of school children in the United States and the United Kingdom. The highest prevalence of food allergies is in Australia affecting approximately 10% of young children. It is lower in the developing world.

Apollo signs license option deal with Case Western to develop point-of-care blood analyzer

A blood test yields a wealth of information crucial to a person's health. What's needed is a device that is small and inexpensive, yet capable of quickly providing a thorough analysis using a very small sample.

Gentium completes Defibrotide clinical studies, plans to file for regulatory approval

Gentium S.p.A. today announced that ongoing preclinical and clinical studies on Defibrotide have been completed and confirmed its plan to file for regulatory approval of Defibrotide with the US Food and Drug Administration and the European Medicines Agency by the end of the second quarter of 2011.

Read more Medical News

› Verified 5 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center71
    Adult patient months included in Kt/V greater than or equal to 1.2574
    Percentage of adult patients getting regular hemodialysis at the center95
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    New line of household disinfectant wipes and sprays launched

    Seventh Generation, the nation's leading brand of non-toxic, environmentally safe household solutions, incorporates the latest breakthrough in green chemistry with the introduction of a new line of household disinfectant wipes and sprays.

    Tackling food allergies: is immunotherapy the answer?

    Food allergies affect approximately 8% of school children in the United States and the United Kingdom. The highest prevalence of food allergies is in Australia affecting approximately 10% of young children. It is lower in the developing world.

    Apollo signs license option deal with Case Western to develop point-of-care blood analyzer

    A blood test yields a wealth of information crucial to a person's health. What's needed is a device that is small and inexpensive, yet capable of quickly providing a thorough analysis using a very small sample.

    Gentium completes Defibrotide clinical studies, plans to file for regulatory approval

    Gentium S.p.A. today announced that ongoing preclinical and clinical studies on Defibrotide have been completed and confirmed its plan to file for regulatory approval of Defibrotide with the US Food and Drug Administration and the European Medicines Agency by the end of the second quarter of 2011.

    Read more Medical News

    › Verified 5 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Stony Brook Southampton Hospital Regional Dialysis Center with elevated calcium levels.

Patients with hypercalcemia71
Hypercalcemia patient months574
Hypercalcemia patients with serumcalcium greater than 10.2 mg1
Patients with Serumphosphor79
Patients with Serumphosphor less than 3.5 mg/dL6
Patients with Serumphosphor from 3.5 to 4.5 mg/dL20
Patients with Serumphosphor from 4.6 to 5.5 mg/dL36
Patients with Serumphosphor from 5.6 to 7 mg/dL27
Patients with Serumphosphor greater than 7 mg/dL11

News Archive

New line of household disinfectant wipes and sprays launched

Seventh Generation, the nation's leading brand of non-toxic, environmentally safe household solutions, incorporates the latest breakthrough in green chemistry with the introduction of a new line of household disinfectant wipes and sprays.

Tackling food allergies: is immunotherapy the answer?

Food allergies affect approximately 8% of school children in the United States and the United Kingdom. The highest prevalence of food allergies is in Australia affecting approximately 10% of young children. It is lower in the developing world.

Apollo signs license option deal with Case Western to develop point-of-care blood analyzer

A blood test yields a wealth of information crucial to a person's health. What's needed is a device that is small and inexpensive, yet capable of quickly providing a thorough analysis using a very small sample.

Gentium completes Defibrotide clinical studies, plans to file for regulatory approval

Gentium S.p.A. today announced that ongoing preclinical and clinical studies on Defibrotide have been completed and confirmed its plan to file for regulatory approval of Defibrotide with the US Food and Drug Administration and the European Medicines Agency by the end of the second quarter of 2011.

Read more Medical News

› Verified 5 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 79
Patient months included in arterial venous fistula and catheter summaries 506
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment79
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer11

News Archive

New line of household disinfectant wipes and sprays launched

Seventh Generation, the nation's leading brand of non-toxic, environmentally safe household solutions, incorporates the latest breakthrough in green chemistry with the introduction of a new line of household disinfectant wipes and sprays.

Tackling food allergies: is immunotherapy the answer?

Food allergies affect approximately 8% of school children in the United States and the United Kingdom. The highest prevalence of food allergies is in Australia affecting approximately 10% of young children. It is lower in the developing world.

Apollo signs license option deal with Case Western to develop point-of-care blood analyzer

A blood test yields a wealth of information crucial to a person's health. What's needed is a device that is small and inexpensive, yet capable of quickly providing a thorough analysis using a very small sample.

Gentium completes Defibrotide clinical studies, plans to file for regulatory approval

Gentium S.p.A. today announced that ongoing preclinical and clinical studies on Defibrotide have been completed and confirmed its plan to file for regulatory approval of Defibrotide with the US Food and Drug Administration and the European Medicines Agency by the end of the second quarter of 2011.

Read more Medical News

› Verified 5 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary66
Hospitalization Rate in facility291.5 (Worse than Expected)
Hospitalization Rate: Upper Confidence Limit436.7
Hospitalization Rate: Lower Confidence Limit200.1

News Archive

New line of household disinfectant wipes and sprays launched

Seventh Generation, the nation's leading brand of non-toxic, environmentally safe household solutions, incorporates the latest breakthrough in green chemistry with the introduction of a new line of household disinfectant wipes and sprays.

Tackling food allergies: is immunotherapy the answer?

Food allergies affect approximately 8% of school children in the United States and the United Kingdom. The highest prevalence of food allergies is in Australia affecting approximately 10% of young children. It is lower in the developing world.

Apollo signs license option deal with Case Western to develop point-of-care blood analyzer

A blood test yields a wealth of information crucial to a person's health. What's needed is a device that is small and inexpensive, yet capable of quickly providing a thorough analysis using a very small sample.

Gentium completes Defibrotide clinical studies, plans to file for regulatory approval

Gentium S.p.A. today announced that ongoing preclinical and clinical studies on Defibrotide have been completed and confirmed its plan to file for regulatory approval of Defibrotide with the US Food and Drug Administration and the European Medicines Agency by the end of the second quarter of 2011.

Read more Medical News

› Verified 5 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Stony Brook Southampton Hospital Regional Dialysis Center were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility31.5 (As Expected)
Readmission Rate: Upper Confidence Limit44.4
Readmission Rate: Lower Confidence Limit20.3

News Archive

New line of household disinfectant wipes and sprays launched

Seventh Generation, the nation's leading brand of non-toxic, environmentally safe household solutions, incorporates the latest breakthrough in green chemistry with the introduction of a new line of household disinfectant wipes and sprays.

Tackling food allergies: is immunotherapy the answer?

Food allergies affect approximately 8% of school children in the United States and the United Kingdom. The highest prevalence of food allergies is in Australia affecting approximately 10% of young children. It is lower in the developing world.

Apollo signs license option deal with Case Western to develop point-of-care blood analyzer

A blood test yields a wealth of information crucial to a person's health. What's needed is a device that is small and inexpensive, yet capable of quickly providing a thorough analysis using a very small sample.

Gentium completes Defibrotide clinical studies, plans to file for regulatory approval

Gentium S.p.A. today announced that ongoing preclinical and clinical studies on Defibrotide have been completed and confirmed its plan to file for regulatory approval of Defibrotide with the US Food and Drug Administration and the European Medicines Agency by the end of the second quarter of 2011.

Read more Medical News

› Verified 5 days ago

Infection Rate

Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Stony Brook Southampton Hospital Regional Dialysis Center get infections in their blood each year compared to the number of infections expected for the center based on the national average.

Standard Infection Summary Ratio(SIR) YearJanuary, 2016 - December, 2016
Infection Rate in facility.22 (As Expected)
SIR: Upper Confidence Limit1.09
SIR: Lower Confidence Limit.01

News Archive

New line of household disinfectant wipes and sprays launched

Seventh Generation, the nation's leading brand of non-toxic, environmentally safe household solutions, incorporates the latest breakthrough in green chemistry with the introduction of a new line of household disinfectant wipes and sprays.

Tackling food allergies: is immunotherapy the answer?

Food allergies affect approximately 8% of school children in the United States and the United Kingdom. The highest prevalence of food allergies is in Australia affecting approximately 10% of young children. It is lower in the developing world.

Apollo signs license option deal with Case Western to develop point-of-care blood analyzer

A blood test yields a wealth of information crucial to a person's health. What's needed is a device that is small and inexpensive, yet capable of quickly providing a thorough analysis using a very small sample.

Gentium completes Defibrotide clinical studies, plans to file for regulatory approval

Gentium S.p.A. today announced that ongoing preclinical and clinical studies on Defibrotide have been completed and confirmed its plan to file for regulatory approval of Defibrotide with the US Food and Drug Administration and the European Medicines Agency by the end of the second quarter of 2011.

Read more Medical News

› Verified 5 days ago

Transfusion Summary

Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Stony Brook Southampton Hospital Regional Dialysis Center's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.

Standard Transfusion Summary Ratio (STrR) Year January, 2016 - December, 2016
Patients in facility's Transfusion Summary 49
Transfusion Rate in facility61 (As Expected)
Transfusion Rate: Upper Confidence Limit140.3
Transfusion Rate: Lower Confidence Limit29.4

News Archive

New line of household disinfectant wipes and sprays launched

Seventh Generation, the nation's leading brand of non-toxic, environmentally safe household solutions, incorporates the latest breakthrough in green chemistry with the introduction of a new line of household disinfectant wipes and sprays.

Tackling food allergies: is immunotherapy the answer?

Food allergies affect approximately 8% of school children in the United States and the United Kingdom. The highest prevalence of food allergies is in Australia affecting approximately 10% of young children. It is lower in the developing world.

Apollo signs license option deal with Case Western to develop point-of-care blood analyzer

A blood test yields a wealth of information crucial to a person's health. What's needed is a device that is small and inexpensive, yet capable of quickly providing a thorough analysis using a very small sample.

Gentium completes Defibrotide clinical studies, plans to file for regulatory approval

Gentium S.p.A. today announced that ongoing preclinical and clinical studies on Defibrotide have been completed and confirmed its plan to file for regulatory approval of Defibrotide with the US Food and Drug Administration and the European Medicines Agency by the end of the second quarter of 2011.

Read more Medical News

› Verified 5 days ago

Survival Summary

The rate of mortality show you whether patients who were being treated regularly at Stony Brook Southampton Hospital Regional Dialysis Center lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.

Standard Survival Summary Ratio(SIR) YearJanuary, 2013 - December, 2016
Patients in facility's Survival Summary353
Mortality Rate in facility17.9 (As Expected)
Mortality Rate: Upper Confidence Limit23.5
Mortality Rate: Lower Confidence Limit13.4

News Archive

New line of household disinfectant wipes and sprays launched

Seventh Generation, the nation's leading brand of non-toxic, environmentally safe household solutions, incorporates the latest breakthrough in green chemistry with the introduction of a new line of household disinfectant wipes and sprays.

Tackling food allergies: is immunotherapy the answer?

Food allergies affect approximately 8% of school children in the United States and the United Kingdom. The highest prevalence of food allergies is in Australia affecting approximately 10% of young children. It is lower in the developing world.

Apollo signs license option deal with Case Western to develop point-of-care blood analyzer

A blood test yields a wealth of information crucial to a person's health. What's needed is a device that is small and inexpensive, yet capable of quickly providing a thorough analysis using a very small sample.

Gentium completes Defibrotide clinical studies, plans to file for regulatory approval

Gentium S.p.A. today announced that ongoing preclinical and clinical studies on Defibrotide have been completed and confirmed its plan to file for regulatory approval of Defibrotide with the US Food and Drug Administration and the European Medicines Agency by the end of the second quarter of 2011.

Read more Medical News

› Verified 5 days ago


Dialysis Facility in Hampton Bays, NY

Stony Brook Southampton Hospital Regional Dialysis Center
Location: 184 West Montauk Hgwy, Hampton Bays, New York, 11946
Phone: (631) 723-4200

News Archive

New line of household disinfectant wipes and sprays launched

Seventh Generation, the nation's leading brand of non-toxic, environmentally safe household solutions, incorporates the latest breakthrough in green chemistry with the introduction of a new line of household disinfectant wipes and sprays.

Tackling food allergies: is immunotherapy the answer?

Food allergies affect approximately 8% of school children in the United States and the United Kingdom. The highest prevalence of food allergies is in Australia affecting approximately 10% of young children. It is lower in the developing world.

Apollo signs license option deal with Case Western to develop point-of-care blood analyzer

A blood test yields a wealth of information crucial to a person's health. What's needed is a device that is small and inexpensive, yet capable of quickly providing a thorough analysis using a very small sample.

Gentium completes Defibrotide clinical studies, plans to file for regulatory approval

Gentium S.p.A. today announced that ongoing preclinical and clinical studies on Defibrotide have been completed and confirmed its plan to file for regulatory approval of Defibrotide with the US Food and Drug Administration and the European Medicines Agency by the end of the second quarter of 2011.

Read more Medical News

› Verified 5 days ago


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.